Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.

Simple item page

Files

Original bundle

Now showing 1 - 1 of 1

Name:: PMID 18774391.pdf
Size:: 547.8 KB
Format:: Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1

Name:: license.txt
Size:: 3.42 KB
Format:: Item-specific license agreed upon to submission
Description:

Collections

Clinical Medicine (Scholarly Publications)
RSS Feeds